Clinical trials
Phase 2 Constipation trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 3 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bausch Health Americas, Inc. | 5 |
| Braintree Laboratories | 5 |
| Glycyx Therapeutics | 3 |
| Mayo Clinic | 3 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Enterin Inc. | 2 |
| Ironwood Pharmaceuticals, Inc. | 2 |
| 4D pharma plc | 1 |
| Albireo | 1 |
| Alfasigma S.p.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Constipation | 45 |
| Diarrhea | 6 |
| Irritable Bowel Syndrome | 5 |
| Opioid-Induced Constipation | 5 |
| Parkinson Disease | 4 |
| Neoplasms | 3 |
| Abdominal Pain | 2 |
| Autism Spectrum Disorder | 2 |
| Autistic Disorder | 2 |
| Digestive System Diseases | 2 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.